新型冠狀病毒肺炎患者經鼻高流量氧療使用管理專家共識_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

倪忠 ¹ ^* , 秦浩 ² ^* , 李潔 ³ ^* , 王啟星 ⁴ , 王俊 ² , 景國強 ⁵ , 徐亮 ⁶ , 代冰 ⁷ , 王勝昱 ⁸ , 葛慧青 ⁹ , 夏金根 ¹⁰ , 劉凱 ¹¹ , 何國軍 ¹² , 陳榮璋 ¹³ , 方毅敏 ¹⁴ , 梁宗安 ¹ , 陳榮昌 ¹⁵ ,  張偉 ² ,  羅鳳鳴；中華醫學會呼吸病學分會呼吸治療學組

1. ;
2. ;
3. ;
4. ;
5. ;
6. ;
7. ;
8. ;
9. ;
10. ;
11. ;
12. ;
13. ;
14. ;
15. ;

Corresponding?author：

張偉, Email: zhangweismmu@126.com; 羅鳳鳴；中華醫學會呼吸病學分會呼吸治療學組, Email: luofengming@hotmail.com

Keywords：

DOI：

10.7507/1671-6205.202002031

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 倪忠, 秦浩, 李潔, 王啟星, 王俊, 景國強, 徐亮, 代冰, 王勝昱, 葛慧青, 夏金根, 劉凱, 何國軍, 陳榮璋, 方毅敏, 梁宗安, 陳榮昌, 張偉, 羅鳳鳴；中華醫學會呼吸病學分會呼吸治療學組. 新型冠狀病毒肺炎患者經鼻高流量氧療使用管理專家共識. Chinese Journal of Respiratory and Critical Care Medicine, 2020, 19(2): 110-115. doi: 10.7507/1671-6205.202002031 Copy

1.	國家衛生健康委辦公廳國家中醫藥管理局辦公室《新型冠狀病毒感染的肺炎診療方案 (試行第五版)》[EB/OL].http://www.nhc.gov.cn/yzygj/s7653p/202002/3b09b894ac9b4204a79db5b8912d4440.shtml.
2.	中華醫學會呼吸病學分會呼吸危重癥醫學學組中國醫師協會呼吸醫師分會危重癥醫學工作委員會. 成人經鼻高流量濕化氧療臨床規范應用專家共識. 中華結核與呼吸雜志, 2019, 42(2): 83-91.
3.	羅裕鋒, 瞿嶸, 凌云, 等. 中國首例輸入性中東呼吸綜合征患者經鼻高流量氧療的效果觀察. 中華危重病急救醫學, 2015, 27(10): 841-844.
4.	Roca O, Caralt B, MessikaJ, et al. an index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy. Am J Respir Crit Care Med, 2019, 199(11): 1368-1376.
5.	Chen NS, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 2020, 395(10223): 507-513.
6.	WHO. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: Interim guidance. https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf.
7.	Hui DS, Chow BK, Lo T, et al. Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks. Eur Respir J, 2019, 53(4): pii1802339.
8.	Kang BJ, Koh Y, Lim CM, et al. Failure of high-flow nasal cannula therapy may delay intubation and increase mortality. Intensive Care Med, 2015, 41(4): 623-632.
9.	Rochwerg B, Granton D, Wang DX, et al. High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis. Intensive Care Med, 2019, 45(5): 563-572.
10.	Rello J, Pérez M, Roca O, et al. High-flow nasal therapy in adults with severe acute respiratory infection: a cohort study in patients with 2009 influenza A/H1N1v. J Crit Care, 2012, 27(5): 434-439.
11.	Frat JP, Thille AW, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med, 2015, 372(23): 2185-2196.
12.	Guitton C, Ehrmann S, Volteau C, et al. Nasal high-flow preoxygenation for endotracheal intubation in the critically ill patient: a randomized clinical trial. Intensive Care Med, 2019, 45(4): 447-458.
13.	Mauri T, Turrini C, Eronia N, et al. Physiologic effects of high-flow nasal cannula in acute hypoxemic respiratory failure. Am J Respir Crit Care Med, 2017, 195(9): 1207-1215.
14.	Weber DJ, Rutala WA. Nosocomial infections associated with respiratory therapy. InHospital Epidemiology and Infection Control 3rd edition. Edited by: Mayhall CG. Baltimore: Williams & Wilkins, 1996, 748-758.
15.	Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA, 2020, 323(11): 1061-1069.
16.	Ding L, Wang L, Ma W, et al. Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study. Crit Care, 2020, 24(1): 28.
17.	Pisani L, Astuto M, Prediletto I, et al. High flow through nasal cannula in exacerbated COPD patients: a systematic review. Pulmonology, 2019, 25(6): 348-354.
18.	Norkien? I, d'Espiney R, Martin-Lazaro JF. Effectiveness of high-flow nasal oxygen therapy in management of acute hypoxemic and hypercapnic respiratory failure. Acta Med Litu, 2019, 26(1): 46-50.
19.	Nishimura M. High-flow nasal cannula oxygen therapy devices. Respir Care, 2019, 64(6): 735-742.
20.	García-de-Acilu M, Patel BK, Roca O, et al. Noninvasive approach for de novo acute hypoxemic respiratory failure: noninvasive ventilation, high-flow nasal cannula, both or none?. Curr Opin Crit Care, 2019, 25(1): 54-62.
21.	Di Mussi R, Spadaro S, Stripoli T, et al. High-flow nasal cannula oxygen therapy decreases postextubation neuroventilatory drive and work of breathing in patients with chronic obstructive pulmonary disease. Crit Care, 2018, 22(1): 180.
22.	Koyauchi T, Hasegawa H, Kanata K, et al. Efficacy and tolerability of high-flow nasal cannula oxygen therapy for hypoxemic respiratory failure in patients with interstitial lung disease with do-not-intubate orders: a retrospective single-center study. Respiration, 2018, 96(4): 323-329.
23.	Kim ES, Lee H, Kim SJ, et al. Effectiveness of high-flow nasal cannula oxygen therapy for acute respiratory failure with hypercapnia. J Thorac Dis, 2018, 10(2): 882-888.
24.	Lee MK, Choi J, Park B, et al. High flow nasal cannulae oxygen therapy in acute-moderate hypercapnic respiratory failure. Clin Respir J, 2018, 12(6): 2046-2056.

1. 國家衛生健康委辦公廳國家中醫藥管理局辦公室《新型冠狀病毒感染的肺炎診療方案 (試行第五版)》[EB/OL].http://www.nhc.gov.cn/yzygj/s7653p/202002/3b09b894ac9b4204a79db5b8912d4440.shtml.
2. 中華醫學會呼吸病學分會呼吸危重癥醫學學組中國醫師協會呼吸醫師分會危重癥醫學工作委員會. 成人經鼻高流量濕化氧療臨床規范應用專家共識. 中華結核與呼吸雜志, 2019, 42(2): 83-91.
3. 羅裕鋒, 瞿嶸, 凌云, 等. 中國首例輸入性中東呼吸綜合征患者經鼻高流量氧療的效果觀察. 中華危重病急救醫學, 2015, 27(10): 841-844.
4. Roca O, Caralt B, MessikaJ, et al. an index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy. Am J Respir Crit Care Med, 2019, 199(11): 1368-1376.
5. Chen NS, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 2020, 395(10223): 507-513.
6. WHO. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: Interim guidance. https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf.
7. Hui DS, Chow BK, Lo T, et al. Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks. Eur Respir J, 2019, 53(4): pii1802339.
8. Kang BJ, Koh Y, Lim CM, et al. Failure of high-flow nasal cannula therapy may delay intubation and increase mortality. Intensive Care Med, 2015, 41(4): 623-632.
9. Rochwerg B, Granton D, Wang DX, et al. High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis. Intensive Care Med, 2019, 45(5): 563-572.
10. Rello J, Pérez M, Roca O, et al. High-flow nasal therapy in adults with severe acute respiratory infection: a cohort study in patients with 2009 influenza A/H1N1v. J Crit Care, 2012, 27(5): 434-439.
11. Frat JP, Thille AW, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med, 2015, 372(23): 2185-2196.
12. Guitton C, Ehrmann S, Volteau C, et al. Nasal high-flow preoxygenation for endotracheal intubation in the critically ill patient: a randomized clinical trial. Intensive Care Med, 2019, 45(4): 447-458.
13. Mauri T, Turrini C, Eronia N, et al. Physiologic effects of high-flow nasal cannula in acute hypoxemic respiratory failure. Am J Respir Crit Care Med, 2017, 195(9): 1207-1215.
14. Weber DJ, Rutala WA. Nosocomial infections associated with respiratory therapy. InHospital Epidemiology and Infection Control 3rd edition. Edited by: Mayhall CG. Baltimore: Williams & Wilkins, 1996, 748-758.
15. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA, 2020, 323(11): 1061-1069.
16. Ding L, Wang L, Ma W, et al. Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study. Crit Care, 2020, 24(1): 28.
17. Pisani L, Astuto M, Prediletto I, et al. High flow through nasal cannula in exacerbated COPD patients: a systematic review. Pulmonology, 2019, 25(6): 348-354.
18. Norkien? I, d'Espiney R, Martin-Lazaro JF. Effectiveness of high-flow nasal oxygen therapy in management of acute hypoxemic and hypercapnic respiratory failure. Acta Med Litu, 2019, 26(1): 46-50.
19. Nishimura M. High-flow nasal cannula oxygen therapy devices. Respir Care, 2019, 64(6): 735-742.
20. García-de-Acilu M, Patel BK, Roca O, et al. Noninvasive approach for de novo acute hypoxemic respiratory failure: noninvasive ventilation, high-flow nasal cannula, both or none?. Curr Opin Crit Care, 2019, 25(1): 54-62.
21. Di Mussi R, Spadaro S, Stripoli T, et al. High-flow nasal cannula oxygen therapy decreases postextubation neuroventilatory drive and work of breathing in patients with chronic obstructive pulmonary disease. Crit Care, 2018, 22(1): 180.
22. Koyauchi T, Hasegawa H, Kanata K, et al. Efficacy and tolerability of high-flow nasal cannula oxygen therapy for hypoxemic respiratory failure in patients with interstitial lung disease with do-not-intubate orders: a retrospective single-center study. Respiration, 2018, 96(4): 323-329.
23. Kim ES, Lee H, Kim SJ, et al. Effectiveness of high-flow nasal cannula oxygen therapy for acute respiratory failure with hypercapnia. J Thorac Dis, 2018, 10(2): 882-888.
24. Lee MK, Choi J, Park B, et al. High flow nasal cannulae oxygen therapy in acute-moderate hypercapnic respiratory failure. Clin Respir J, 2018, 12(6): 2046-2056.

Previous Article
新型冠狀病毒肺炎患者全病程管控關鍵技術集成與優化應用
Next Article
新型冠狀病毒肺炎患者呼吸機使用感控管理專家共識

Chinese Journal of Respiratory and Critical Care Medicine

新型冠狀病毒肺炎患者經鼻高流量氧療使用管理專家共識

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content